%{{tag.tag}} {{articledata.title}} {{moment(articledata.cdate)}} @{{articledata.company.replace(" ","")}} comment This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership announcement. Women's health innovator %EvofemBiosciences Inc. (OTC: $EVFM ) announced in a press release today a new market partnership with %Telemedicine company Hello Alpha to offer an FDA-approved solution to prevent pregnancy for those who choose to use an on-demand method of birth control. Hello Alpha is a telemedicine company with a medical team specifically trained for women’s unique needs. The solutions being offered by Hello Alpha and Evofem are designed to complement the use of GLP-1 medications, which can potentially reduce the effectiveness of birth control pills during specific intervals within the dosing cycle. Shares were trading almost 20 percent higher in morning activity.